Recent funding decisions
Find the full details of our most recent decisions relating to ADHD treatments.
A time of change
2024 and 2025 have seen a lot of change for the funding of stimulant medicines.
Before we make a final decision, we hold a consultation period. We want to hear from everyone to help us make the best decision.
Recent consultation
We have recently consulted on funding another brand of modified-release methylphenidate. Our final decision will be published in early 2026.
Proposal to fund another new brand of methylphenidate hydrochloride
Dig into some detail
Did you know that we publish information we've released under the Official Information Act? Search for ADHD, stimulants, methylphenidate, and more among our recent information releases.